Df Dent & CO Inc Exact Sciences Corp Transaction History

Df Dent & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $195,750 - $271,836	-2,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $150,525 - $250,425	2,700 New	2,700 $235,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $102,330 - $281,988	-2,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $23,298 - $29,922	-300 Reduced 10.0%	2,700 $250,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $185,940 - $289,500	3,000 New	3,000 $260,000
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $168,120 - $247,980	-3,000 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$48.29 - $80.6 $144,870 - $241,799	3,000 New	3,000 $237,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Df Dent & CO Inc with notifications on news.